The content on this site is intended for healthcare professionals only
Princess Margaret Hospital and University of Toronto, Canada
Published: 28 Nov 2008
Views: 15264
Prof. Ian Tannock
Blood pressure and efficacy in patients with metastatic renal cell carcinoma receiving axitinib, from ESMO 2008
- Categories:
- Prostate & urology
Related Videos
Intraoperative Radiotherapy
Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal
25 Sep 2022
Potential for enfortumab vedotin plus pembrolizumab in cisplatin-ineligible loca...
Prof Jonathan E Rosenberg - Memorial Sloan Kettering Cancer Center, New York Cit...
14 Sep 2022
Updates in prostate cancer from ESMO 2022
Prof Eleni Efstathiou, Prof Gerhardt Attard and Prof Boris Hadaschik
12 Sep 2022
Latest in mRCC from ESMO 2022
Dr Javier Puente, Dr Bernard Escudier, Prof Viktor Grünwald and Prof Stéphane Ou...
12 Sep 2022
ESMO 2022: Latest in PARP inhibitors for metastatic prostate cancer
Dr Neal Shore, Dr Pasquale Rescigno, Prof Noel Clarke and Dr Friederike Schlürma...
11 Sep 2022
Bladder cancer: Current state and future directions in treatment
Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case ...
15 Aug 2022
Optimum treatment algorithm in management of advanced prostate cancer
Prof Jorge Garcia - GU Medical Oncology Program, UH Seidman Cancer Center, Case ...
15 Aug 2022
Prostate cancer screening: A novel risk prediction tool with standard biopsies v...
Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden
20 Jul 2022
Updates from the PROpel and MAGNITUDE studies
Prof Phil Cornford and Dr Elena Castro
11 Jul 2022